Stoke Therapeutics, Inc. (STOK) Operating cash flow 2018–2025
Stoke Therapeutics, Inc. (STOK) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$45.6MFY2025 · since FY2018: -$11.0M → $45.6M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $45.6M | +152.5% |
| FY2024 | -$86.9M | -7.1% |
| FY2023 | -$81.1M | -154.4% |
| FY2022 | -$31.9M | +52.4% |
| FY2021 | -$66.9M | -58.5% |
| FY2020 | -$42.2M | -36.0% |
| FY2019 | -$31.1M | -183.2% |
| FY2018 | -$11.0M | — |
Source: SEC XBRL filings · For reference only · Not investment advice